TipRanks
Vertex Pharmaceuticals (IT:1VRTX)
:1VRTX

Compare Vertex Pharmaceuticals (1VRTX) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
€471.90
€113.82B
29.63
33.71%
21 Buy
4 Hold
1 Sell
Strong Buy
Alnylam Pharma
$240.08
$31.88B
39.24
-48.11%
19 Buy
3 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$12.48B
170.34
20.00%
15 Buy
5 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$2.19B
-13.72
9.17%
4 Buy
8 Hold
4 Sell
Hold
Intellia Therapeutics
$13.51
$1.59B
-3.42
-6.36%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.01B
-10.97
-14.68%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IT:1VRTX
Vertex Pharmaceuticals
445.60
113.80
34.30%
ALNY
Alnylam Pharma
239.36
-212.37
-47.01%
BMRN
BioMarin Pharmaceutical
64.73
10.36
19.05%
SRPT
Sarepta Therapeutics
19.76
2.71
15.89%
NTLA
Intellia Therapeutics
11.49
-0.92
-7.41%
CRSP
Crispr Therapeutics AG
52.21
-6.86
-11.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts